What question did this study set out to answer?

To evaluate T1 and T2 mapping's effectiveness in identifying kidney injury from chronic liver disease and assessing stem cell therapy outcomes.

March 19, 2026Open Access

The Value of T1 and T2 Mapping in Diagnosing Chronic Liver Disease–related Kidney Injury and Monitoring the Outcome of Stem Cell Therapy: An Animal Experimental Study

Key Points

To evaluate T1 and T2 mapping's effectiveness in identifying kidney injury from chronic liver disease and assessing stem cell therapy outcomes.
Conducted an animal experimental study
Used T1 and T2 mapping for assessment
Administered bone marrow mesenchymal stem cells (BMSCs)
Monitored kidney injury and treatment outcomes
Demonstrated increased effectiveness of T1 and T2 mapping in diagnosing kidney injury
Showed positive correlation between T1/T2 values and kidney function
Highlighted potential of BMSCs in ameliorating kidney damage

Abstract

Purpose: To evaluate the monitoring value of T1 and T2 mapping in assessing kidney injury associated with chronic liver disease and the therapeutic efficacy of bone marrow mesenchymal stem cells (BMSCs) treatment.

Bookmark

View Full Paper

Cite This Study

Qin et al. (Thu,) studied this question.

synapsesocial.com/papers/69bb91c7496e729e6297f3ba https://doi.org/https://doi.org/10.2463/mrms.mp.2025-0098

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Bookmark

View Full Paper